Abstract
I read with interest two excellent articles in the June 2017 issue. One described the main pharmacogenomic tests available in Australia and their relevance to clinical practice.1 The other highlighted concerns with direct-to-consumer genetic testing, particularly the over-enthusiastic promotion and difficulties in actioning test results.
Original language | English |
---|---|
Number of pages | 1 |
Journal | Australian Prescriber |
Volume | 40 |
Issue number | 5 |
DOIs | |
Publication status | Published - 3 Oct 2017 |
Keywords
- Pharmacology
- pharmacogenomics
- prescribing